A new study reports how low smell test scores correlate with the onset of dementia and Alzheimer’s disease, and could act to predict onset, to a certain degree.
Preparing your home to care for a loved one with Alzheimer's Disease or dementia can be difficult. By Carole B. LarkinAlzheimer's Reading RoomFor many people, their home represents their life accomplishments; this is especially true for individuals diagnosed with dementia or Alzheimer’s disease and their caregivers. Show More Summary
Alzheimer's Patients can remember. By Bob DeMarcoAlzheimer's Reading RoomWhat they remember is stored in their brain before the onset of Alzheimer's disease. How to Get Answers To Your Questions About Alzheimer's and Dementia Listen to the podcast. Show More Summary
Resveratrol, given to Alzheimer's patients, appears to restore the integrity of the blood-brain barrier, reducing the ability of harmful immune molecules secreted by immune cells to infiltrate from the body into brain tissues, say researchers. Show More Summary
TauRx Pharmaceuticals’ experimental Alzheimer’s drug LMTX failed to improve cognitive and functional skills in patients with mild to moderate Alzheimer’s disease, a large, late-stage study showed. But the drug did show a benefit in a...Show More Summary
An FDA approved drug to treat renal cell carcinoma appears to reduce levels of a toxic brain protein linked to dementia in Alzheimer's and Parkinson's diseases when given to animals. This finding is the latest from Georgetown University...Show More Summary
TauRx, a privately held drug company in Singapore that has focused on a daring alternative approach to attacking Alzheimer's disease, released results this morning of an 891-patient study of its experimental drug, LMTX. The study failed, with patients on LMTX faring no better than those on placebo, but TauRX may [...]
A drug that targets tau tangles in the brain has produced strong results in a large clinical trial, slowing the progression of the disease in hundreds of people
A large fraction of the public funding devoted to aging research goes towards Alzheimer's disease, a very broad set of initiatives that dovetail with other large investments in mapping and understanding the biochemistry of the brain....Show More Summary
Two studies involving University of Waterloo researchers presented this week at the 2016 Alzheimer's Association International Conference (AAIC) in Toronto highlight a new diagnostic tool that can identify Alzheimer's disease long before the onset of symptoms as well as the increasing prevalence of Alzheimer's disease in Ontario. Window to the brain read more
NEW YORK, NY, July 26, 2016 - Researchers from Columbia University Medical Center (CUMC), New York State Psychiatric Institute, and NewYork-Presbyterian reported that an odor identification test may prove useful in predicting cognitive...Show More Summary
2016Mayo neuroscientist Melissa E. Murray, Ph.D., led the study, which suggests a high number of men are not accurately diagnosed during their lifetime. The Alzheimer’s Association issued a news release today about the research findings, which Dr. Murray is presenting at the 2016 Alzheimer’s Association International Conference in Toronto. “While it is well accepted that […]
Caring for a loved one with Alzheimer's disease or other forms of dementia is not easy. The daily struggles can weigh heavily on everyone in the household. Mayo Clinic experts say it is critical for caregivers to take time to care for themselves. In this Mayo Clinic Minute, reporter Vivien Williams discusses caregiving with Dr. […]
Alzheimer’s disease (AD) is a neurodegenerative condition and the most common form of dementia worldwide, accounting for around 70% of dementia cases. Deposition of the amyloid-beta (A-beta) peptide in the form of amyloid plaques is one of the hallmarks of the disease, occurring early in the development of this condition. As disease progresses, degenerative changes […]
A new diagnostic tool that can identify Alzheimer's disease long before the onset of symptoms has been presented by researchers. They add that the tool also highlights the increasing prevalence of Alzheimer's disease in Ontario.
An odor identification test may prove useful in predicting cognitive decline and detecting early-stage Alzheimer's disease, according to research presented at the Alzheimer's Association International Conference.
DEAR MAYO CLINIC: How soon can Alzheimer’s disease be diagnosed? What are the early symptoms to watch for? ANSWER: There is no one test that can be used to diagnose Alzheimer’s disease. But, based on an assessment of symptoms, along with a variety of tests and exams, Alzheimer’s often can be identified in its earliest […]
Certain genes make you more likely to develop Alzheimer's disease. Genes control the function of every cell in your body. Some genes determine basic characteristics, such as the color of your eyes and hair. Other genes can make you more likely to develop certain diseases, including Alzheimer's disease. Researchers have identified a number of genes associated […]
The first case of Alzheimer's disease diagnosed in an HIV-positive individual has been documented. The finding in a 71-year-old man triggers a realization about HIV survivors now reaching the age when Alzheimer's risk begins to escalate.
The accumulation of ?-Amyloid (??) and tau proteins in the brain is hallmark pathology for Alzheimer disease. Recently developed positron emission tomography (PET) tracers, including [18F]-AV-1451, bind to tau in neurofibrillary tangles in the brain. Show More Summary